Bepranemab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bepranemab, covering 2025-08-29 to 2025-08-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD) [Phase 2]